Showcases Stock ranks Forex

Teva Pharmaceutical Industries Ltd (TEVA)
10.57  0.15 (1.44%) 05-14 16:00
Open: 10.22 Pre. Close: 10.25
High: 10.65 Low: 10.2
Volume: 8,367,913 Market Cap: 12,128M
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, the company provides specialty medicines for use in central nervous system and respiratory indications. Further, its products in the central nervous system and pain area comprise Copaxone for the treatment of relapsing forms of MS; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. Additionally, the company's products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Braltus, Cinqair/Cinqaero, and AirDuo RespiClick/ArmonAir RespiClick/AirDuo Digihaler for the treatment of asthma and chronic obstructive pulmonary disease, as well as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. It has collaboration arrangements with Otsuka Pharmaceutical Co. Ltd. and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 10.651 - 10.688 10.688 - 10.722
Low: 10.095 - 10.142 10.142 - 10.185
Close: 10.494 - 10.561 10.561 - 10.622
Stock Technical Analysis
Target: Six months: 12.99
One year: 15.17
Support: Support1: 10.39
Support2: 9.94
Resistance: Resistance1: 11.12
Resistance2: 12.99
Pivot: 10.41
Moving Averages: MA(5): 10.35
MA(20): 10.36
MA(100): 11.06
MA(250): 10.76
MACD: MACD(12,26): -0.13
Signal(12,26,9): -0.17
%K %D: %K(14,3): 51.06
%D(3): 41.33
RSI: RSI(14): 50.41
52-Week: High: 13.3
Low: 8.44
Change(%): -10.2
Average Vol(K): 3-Month: 863689
10-Days: 872472
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.

TEVA has closed below upper band by 30.6%. Bollinger Bands are 48.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to TEVA's normal range. The bands have been in this narrow range for 6 bars. This is a sign that the market may be about to initiate a new trend.
Stock chart
Stock News
Thu, 13 May 2021
Insider Selling: Teva Pharmaceutical Industries Limited (NYSE:TEVA) VP Sells 37,884 Shares of Stock - MarketBeat

Wed, 12 May 2021
Teva Pharmaceutical Industries (TEVA) Shares Cross Above 200 DMA - Nasdaq

Wed, 05 May 2021
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report - Business Wire

Tue, 04 May 2021
Teva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in the United States - Business Wire

Mon, 03 May 2021
Teva Pharma To Present Data From 3-yr Open-label Extension Study Of AUSTEDO Tablets - Nasdaq

Thu, 29 Apr 2021
United States Generic Drugs Market Report 2021 Featuring Teva Pharmaceutical Industries, Mylan NV, Sandoz, Endo Pharmaceuticals, Lupin, Dr Reddy's and Sun pharma - PRNewswire

Financial Analysis
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 1100.00
Shares Float (M) 1100.00
% Held by Insiders 0.78
% Held by Institutions 52.18
Shares Short (K) 29830
Shares Short Prior Month (K) 36370
Stock Financials
EPS -3.630
Book Value (p.s.) 9.070
Profit Margin -24.45
Operating Margin 17.61
Return on Assets (ttm) 3.4
Return on Equity (ttm) -31.6
Qtrly Rev. Growth -8.6
Gross Profit (p.s.) 7.027
Sales Per Share 14.800
EBITDA (p.s.) 4.000
Qtrly Earnings Growth 11.60
Operating Cash Flow (M) 506.00
Levered Free Cash Flow (M) 1380.00
Stock Valuation
PE Ratio -2.91
PEG Ratio
Price to Book value 1.17
Price to Sales 0.71
Price to Cash Flow 22.98
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator